Nikolaus Marx
0000-0001-6141-634X
16 papers found
Refreshing results…
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials
Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells
Cardiovascular Disease in Chronic Kidney Disease
Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin
Loss of CASK Accelerates Heart Failure Development
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Screen-detected atrial fibrillation predicts mortality in elderly subjects
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial
Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t
Post-cardiac injury syndrome after transcatheter mitral valve repair using MitraClip system: a case report
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
Reduction of cardiovascular risk in patients with T2DM by GLP-1 receptor agonists: a shift in paradigm driven by data from large cardiovascular outcome trials
Ivabradine for the Therapy of Chronic Stable Angina Pectoris: a Systematic Review and Meta-Analysis
Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?
Missing publications? Search for publications with a matching author name.